Microcin J25 (MccJ25) is a plasmid-encoded, 21-amino-acid antibacterial peptide produced by Escherichia coli (4, 21) . It is active against E. coli, Salmonella, and Shigella. Four genes (mcjA, mcjB, mcjC, and mcjD) are required for MccJ25 synthesis, export, and immunity (26, 27) . mcjA encodes the primary structure of MccJ25 as a 58-amino-acid precursor, from which a 37-amino-acid N-terminal leader is removed. The 21-residue mature peptide has a compact, extraordinary structure, which consists of an eight-residue lariat ring and a C-terminal tail which folds on itself and passes through the ring, where it is sterically trapped (2, 19, 30) . The mcjB and mcjC gene products are involved in this assembly process (27) . The mcjD product has a dual role. It works as a dedicated ATP-binding cassette (ABC) exporter of MccJ25 and, at the same time, by ensuring rapid secretion from the cytoplasm, protects cells from endogenous MccJ25 synthesized in producer cells, as well as from the exogenous microcin that gains entry (27) .
MccJ25 intake is mediated by the outer membrane receptor FhuA and the inner membrane proteins TonB, ExbB, ExbD, and SbmA (22, 23) . E. coli RNA polymerase is the target of antibiotic action (7, 31) . The binding site for MccJ25 is located in the secondary channel of the enzyme (1, 16) , which provides a route by which the nucleotide substrates reach the catalytic site. Thus, MccJ25 inhibits transcription by clogging the channel and blocking the access of substrates to the active center (1, 16) .
In the course of experiments aimed at cloning an MccJ25-resistant mutation, we found a recombinant plasmid able to confer resistance to the antibiotic, but, unexpectedly, this plasmid did not contain the mutation. Analysis of this plasmid led to the identification of a previously described chromosomal locus, yojI, which, when present in multiple copies, protected cells from MccJ25. Gene disruption experiments showed that a protective effect against MccJ25 was exerted by the single-copy chromosomal gene yojI. On the basis of sequence similarities, yojI had been assumed to encode an ABC-type exporter (18). Here we provide evidence which strongly suggests that the resistance to MccJ25 mediated by YojI involves extrusion of the peptide and that YojI is assisted by the multifunctional outer membrane protein TolC.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The E. coli K-12 strains and plasmids used in this work are described in Table 1 . P1 vir transduction was used to introduce the tolC::Tn10 allele into MC4100 and MG1655. The rich and minimal media used in this work were Luria broth (LB) and M9 minimal salts with 0.2% glucose (15) , respectively. Solid media contained 1.5% agar. Antibiotics were added, when required, at the following final concentrations: ampicillin, 50 g/ml; chloramphenicol, 30 g/ml; and tetracycline, 10 g/ml. Incubations were done at 37°C except for strains bearing the mini-Mu plasmid pEG109 and its derivative pCLO4, which were grown at 30°C.
Sensitivity test and bioassay of microcin activity. Sensitivity to MccJ25 was tested by a spot-on-lawn assay, as follows. Doubling dilutions of a purified MccJ25 preparation were spotted (10 l) onto LB plates and dried. Aliquots (50 l) of cultures to be tested for sensitivity, in the stationary phase, were mixed with 3 ml of top agar (LB containing 0.7% agar) and overlaid onto the plates. After overnight incubation, the plates were examined for different degrees of inhibition.
To test a strain's ability to produce extracellular MccJ25, it was grown on solid LB medium, and a fresh colony was stabbed with a toothpick into the assay plate, which contained M9 medium. After 6 h or 24 h of growth at 37°C, cells were killed with chloroform. The plates were then overlaid with approximately 10 8 sensitive indicator cells in 3 ml of soft agar. The presence of excreted microcin was indicated by a zone of growth inhibition in the lawn of indicator cells surrounding the stabbed colony.
In vivo DNA cloning. In vivo cloning was done by introducing the miniMudII4042-containing plasmid pEG109 (12) into strain SBG231 Mucts. Transformed chloramphenicol-resistant cells were grown and heated at 42°C to induce transposition during phage replication, and strain pop3001.6 was infected with the resulting lysate. Transductants were selected on LB containing chloramphenicol and MccJ25, purified on the same medium, and then rechecked for MccJ25 resistance.
Recombinant DNA methods. Plasmid DNA was isolated with the Wizard miniprep DNA purification system (Promega). Digestion with restriction endonucleases, ligation with T4 DNA ligase, transformation of competent cells by the CaCl 2 procedure, and agarose gel electrophoresis were done as described previously (24) . Automated DNA sequencing was carried out by dideoxy termination (25) . Database searches and sequence alignments were performed with the online BLAST Network Service at the National Center for Biotechnology Infor-mation, National Institutes of Health, Bethesda, Md. Restriction enzymes and DNA ligase were purchased from New England Biolabs.
Construction of a yojI chromosomal deletion. Deletion of the yojI gene was performed by use of the one-step chromosomal gene inactivation method described by Datsenko and Wanner (6) . This technique uses the highly efficient phage Red recombination system encoded on the helper plasmid pKD46 and direct transformation of PCR products consisting of the cat marker gene with extensions identical to the sequences flanking the region targeted for deletion. E. coli strain DH5␣⌬yojI::cat was constructed by transforming strain DH5␣ carrying the Red helper plasmid pKD46 (6) with a PCR product generated by using plasmid pKD3 (6) as the template with primers P1YojI (CTGCGGGCTGTAA TTCATTGTCCGGGTTTTCTGCTGTAGGCTGGAGCTGCTTC) and P2YojI (GACGGCAGCAGTCCGCCAGGTCAGCGTCGTAATACATATGAATAT CCTCCTTAG). These primers included 18 and 20 nucleotides (nt) of priming sites 1 and 2, respectively, of pKD3 and 35-nt homologous extensions flanking the 5Ј and 3Ј ends of the yojI gene. Transformants were selected at 37°C on LB agar containing chloramphenicol. Homologous recombination between the genomic DNA and the PCR product resulted in precise deletion of the entire coding region of yojI and replacement of this region with the cat gene. Representative gene disruption mutants gave a new fragment of the expected size (300 bp) in a PCR test using the locus-specific primer P3YojI (CCATCGACTGCCGCT ACAACC), located 129 nt upstream the start codon of yojI, and the cat-specific primer c1 (TTATACGCAAGGCGACAAGG) (6) . The same primer combination gave negative results with parental strain DH5␣.
RESULTS
Cloning of an E. coli K-12 chromosomal gene that confers resistance to MccJ25 when multiple copies of it are present. Most spontaneous MccJ25-resistant mutants affect outer and inner membrane components involved in MccJ25 intake (22, 23) . In an attempt to identify the MccJ25 intracellular target, we isolated a novel spontaneous MccJ25-resistant mutant of E. coli K-12, designated SBG231. Genetic analysis located the mutation at 90 min on the E. coli genetic map. To clone the mutated gene, a mini-MudII4042 library was made by thermoinduction of strain SBG231 Mucts(pEG109), as described by Groisman et al. (12) , and used to transduce strain pop3001.6. The rationale was that overexpression of the mutant gene would lead to microcin resistance. Transductants were selected on minimal medium supplemented with chloramphenicol and MccJ25. It was expected that only cells transformed with recombinant plasmids containing the mutation would grow. Plasmid DNA was extracted from one of four MccJ25-resistant clones and retransformed into pop3001.6 cells. Cells that received the plasmid, designated pCLO4, became resistant to a high MccJ25 concentration (1 mg/ml), while transformants with the control pEG109 plasmid were fully sensitive. A restriction map of pCLO4 showed that it included approximately 14 kb from the E. coli chromosome (Fig. 1) . Unexpectedly, when we compared the physical map of the fragment cloned in pCLO4 with that of E. coli K-12 (20) , no similarity was detected in the 90-min region. Instead, we found an overlap in the 49-min area. In fact, the fragment carried by pCLO4 was located at approximately 2,304 to 2,318 kb of the E. coli genome (3). This was interpreted to mean that a wild-type locus, and not the mutation we were seeking, was cloned from strain SBG231, which, when present in multiple copies, provided microcin resistance. (Cloning of the mutation at 90 min was achieved by a different approach and established that the RNA polymerase ␤Ј subunit is the MccJ25 target [7] .)
Subcloning of the MccJ25 resistance determinant. Cells containing pCLO4 formed extremely mucoid colonies. This was possibly due to overexpression of rcsB, a gene encoding a positive regulator of colanic acid synthesis (10, 13), which should be encompassed by the segment cloned in pCLO4 (Fig.  1) . It was possible that the colanic acid capsule was responsible for the resistance to MccJ25 because it opposed a permeability barrier to antibiotic entry. This possibility was excluded, however, since a subclone of pCLO4 harboring rcsB (pCLO5 in Fig. 1 ) led to the mucoid phenotype but not to MccJ25 resistance. To identify the locus in pCLO4 responsible for MccJ25 resistance, additional subclones of this plasmid in the vector pUC18 were constructed. Two of them, pCLO6 and pCLO7 (Fig. 1) , were able to confer MccJ25 resistance when they were transformed into DH5␣ cells. In particular, the 4.2-kb PstISmaI insert in pCLO7 should have encompassed only a single complete chromosomal open reading frame (ORF), yojI, flanked by a truncated alkB gene and 1.7 kb from the left end of the mini-Mu vector (Fig. 1) . Sequencing of the ends of the insert and restriction analysis confirmed this organization. These results established that yojI is responsible for MccJ25 resistance.
Recently, Nishino and Yamaguchi (17) constructed a library of 37 E. coli ORFs assumed to be drug transporter genes on the basis of sequence similarities (18) , including seven putative ABC-type ORFs. Among the latter were yojI and the adjacent ORF yojH. Although yojH was first assumed to be a drug resistance gene on the basis of its membrane topology, its product is actually a membrane-associated malate dehydrogenase and the gene has been renamed mqo (28) (Fig. 1A) . Plasmids pUCyojIH, pTrcHyojI, and pTrcHyojH from Nishino and Yamaguchi's library were transformed into DH5␣, and the transformants were tested for their resistance to MccJ25. We added 0.1 mM isopropyl-␤-D-thiogalactopyranoside (IPTG) to agar plates when we examined the susceptibility to MccJ25 of cells harboring the pTrc6His derivatives pTrcHyojI and pTrcHyojH. Cells carrying either pTrcHyojI or pUCyojIH, both of which express YojI, showed complete resistance to MccJ25 (no inhibition halos were detected in a spot-on-lawn test). As expected, synthesis of YojH alone from pTrcHyojH (used as a control) did not lead to resistance. These results confirmed that overexpression of yojI confers MccJ25 resistance.
YojI mediates export of MccJ25. One obvious explanation for the protective effect of YojI against MccJ25 is that it is capable of pumping out MccJ25 molecules, which would keep the intracellular concentration of the peptide below a toxic level. To prove this hypothesis, we tested whether YojI could substitute for McjD, the natural MccJ25 exporter, in secreting MccJ25. We subcloned a 4-kb HindIII-HincII fragment from plasmid pTUC203 (26) into pACYC184. This fragment carries the MccJ25 synthesis genes, mcjABC, but lacks the mcjD sequences encoding the C-terminal 117 amino acids of McjD, including the essential Walker B motif of the ABC exporter. The resulting plasmid, named pTUC348, was expected to be lethal to cells, since in the absence of a functional McjD the MccJ25 peptide would accumulate in host cells and kill them. Therefore, it was transformed into E. coli DH5␣ carrying pJS300 (26), a pUC18 derivative expressing McjD. When a mixture of plasmids pTUC348 (chloramphenicol resistant) and pJS300 (ampicillin resistant) was transformed into DH5␣ cells, selecting only for chloramphenicol resistance, all transformants which appeared were also ampicillin resistant, consistent with absolute coselection for the immunity plasmid pJS300. This expected result indicated that pTUC348 could not be propagated in the absence of an immunity gene. When the plasmid preparation with both pTUC348 and pJS300 was transformed into strain SBG231, containing an MccJ25-resistant RNA polymerase (7), clones harboring only pTUC348 were obtained. These transformants grew normally, indicating that the mutation overcame the inhibitory effect of accumulated internal MccJ25, but they were unable to give growth inhibition halos on an MccJ25-sensitive indicator strain ( Fig.  2A) . Introduction of a second plasmid containing either mcjD (pJS300) or yojI (pCLO7) rescued the MccJ25 secretion phenotype, as shown by the inhibition zones (Fig. 2B and C) . This As noted above, under these assay conditions (6 h of pregrowth before overlaying with indicator cells) strain SBG231 (pTUC348) did not produce a detectable zone of inhibition. However, after the cells were pregrown overnight, a 0.5-cm halo was visible (results not shown). This relatively low-level secretion of MccJ25 may be explained by the presence in SBG231 of the single chromosomal copy of yojI.
TolC is required for microcin J25 secretion by YojI. ABCtype exporters usually function together with a membrane fusion protein (MFP), anchored to the inner membrane by either a single hydrophobic ␣-helix or a covalent lipid moiety, and an outer membrane channel, so that the pumped-out molecules do not accumulate in the periplasm (9) . The yojI gene does not appear to be associated with any gene coding for an MFP, but it is possible that YojI may interact with a member of the MFP family and an outer membrane channel encoded elsewhere on the chromosome. It is noteworthy that McjD, the dedicated exporter of MccJ25, is believed to form a microcin export complex with TolC, but so far, no MFP constituent has been identified for this system (8) . We presumed that TolC might also serve as the channel for the YojI efflux system. If so, the increased MccJ25 resistance seen in strains harboring pCLO7 (yojI ϩ ) would be negated by a tolC mutation. To test this hypothesis, a tolC::Tn10 insertion mutation was transduced into MC4100(pCLO7), and transductants were examined for resistance to MccJ25. The tolC mutation completely eliminated the MccJ25 resistance phenotype. In addition, when the tolC null allele was transduced into SBG231(pTUC348, pCLO7), microcin excretion was abolished. Again, it was necessary to use the microcin-resistant SBG231 background for this assay, since the accumulated microcin kills a TolC Ϫ MccJ25-producing cell. These results strongly suggest that TolC and YojI are components of an efflux complex that uses MccJ25 as a substrate.
Disruption of either tolC or yojI genes leads to increased sensitivity to MccJ25. We have long noticed that in twofold serial dilution assays on LB plates with several E. coli K-12 strains as indicators (including the widely used strains MC4100, MG1655, and DH5␣), MccJ25 gives rise to turbid zones of growth inhibition, except for the first two or three dilutions, which produce clear halos with cloudy edges. As described previously (21) , exposure of sensitive cells to MccJ25 results in filamentous growth. Microscopic observation during formation of a turbid zone of growth inhibition revealed that the cells gradually elongated over the first few hours of incubation. However, most of the filaments recovered and finally developed into colonies, which explains the final turbid appearance. These observations suggested that E. coli strains have intrinsic partial resistance to MccJ25. In light of the results described above, it was tempting to speculate that this phenotype results from removal of MccJ25 from the cells by the YojI-TolC complex. If so, one would predict that disruption of either tolC or yojI would make E. coli cells more sensitive to MccJ25. To test this hypothesis, a tolC::Tn10 mutation was transduced into MC4100 and MG1655, and the strains were examined for sensitivity to MccJ25 in a spot-on-lawn test. The tolC derivatives were at least fourfold more sensitive to exogenous MccJ25 than their wild-type parental strains and gave completely clear spots. Microscopic examination of the halos revealed only isolated cells or short filaments dispersed all over the transparent zones. Apparently, the effect of MccJ25 on the tolC mutant cells was so disruptive that growth and division ceased without any gross changes in morphology. Introduction of plasmid pAX629, which carries a cloned copy of the wildtype tolC gene (14) , into the tolC mutants restored the phenotype of the parent strains, showing that the effect of the tolC mutation on MccJ25 sensitivity is due to inactivation of the tolC gene itself rather than to the possible polarity of the insertion mutation on the expression of a downstream gene.
Next, we compared the resistance to MccJ25 of wild-type and yojI cells. To this end, the chromosomal yojI gene of strain DH5␣ was deleted by the method of Datsenko and Wanner (6), as described in Materials and Methods. A ⌬yojI strain displayed increased susceptibility to MccJ25. In a spot-on-lawn test it was approximately eightfold more sensitive than the control strain DH5␣ and showed completely clear zones of growth inhibition (Fig. 3) .
Taken together, the results described above support the concept that yojI is functional when a single copy is present and that, acting in concert with tolC, it is an important determinant of the baseline resistance of E. coli cells to MccJ25.
DISCUSSION
The main findings of the present study are as follows. Two independent transformants were stabbed (black dots) in each row and pregrown for 6 h before they were overlaid with a lawn of sensitive cells and incubated overnight at 37°C. 
